Gail Kerr is a Rheumatology/Immunology physician affiliated with Howard University. OpenAlex indexes 160 publications with 15,136 citations (h-index 41); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1140 Varnum St NE
Suite #201
Washington, DC 200172151
Telephone
202-832-4200Provider last certified this registry record 29 Mar 2023.
Clinical trials
- Musculoskeletal Ultrasound in Asymptomatic Hyperuricemia
Sponsor: Washington D.C. Veterans Affairs Medical Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
25 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- UCB, Inc.Program year20259 payments
- Novartis Pharmaceuticals CorporationProgram year20258 payments
- SUN PHARMACEUTICAL INDUSTRIES INC.Program year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
60.5%Folate Analog Metabolic Inhibitor26.9%Methotrexate100%Part D≥21 patientsTNF inhibitor13.5%Enbrel Sureclick69%Humira(Cf) Pen31%Part D<11 patients+ 5 more classes in this area
Antiparasitic
21.6%Antimalarial21.6%Hydroxychloroquine Sulfate100%Part D≥13 patientsMetabolism & gastrointestinal
14.1%Corticosteroid10.8%Prednisone100%Part D<11 patientsAminosalicylate3.3%Sulfasalazine100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Genetic, social, and environmental risk factors in rheumatoid arthritis-associated interstitial lung disease
Seminars in Arthritis and Rheumatism
2022 - 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
Arthritis Care & Research
2021 - 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
Arthritis & Rheumatology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Oswaldo Castro, MD
Howard University
Richard Schottenfeld, MD
Howard University
Adeyinka Laiyemo, MD
Howard University
Quyen Chu, MD
Howard University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”